Macular Disease Foundation Australia logo

    Disease Type: AMD

    New treatment for Geographic Atrophy

    The Therapeutic Goods Administration (TGA) approval of the new eye injection treatment SYFOVRE® (pegcetacoplan) is welcome news, as it will give many people with Geographic Atrophy a treatment option that they’ve never had before to slow the progression of the disease.

    Read More
    Meet your team behind the new Eye Connect support service

    Dilini is one of MDFA’s Health Promotion Officers supporting people with age-related macular degeneration through our new Eye Connect service. A qualified Vision Scientist and training Optometrist, let’s find out more about Dilini and her experiences helping people with macular disease, Australia’s leading cause of blindness. 

    Read More
    Loading...